eLife (Oct 2018)

Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody

  • Wen-Fan Shen,
  • Jedhan Ucat Galula,
  • Jyung-Hurng Liu,
  • Mei-Ying Liao,
  • Cheng-Hao Huang,
  • Yu-Chun Wang,
  • Han-Chung Wu,
  • Jian-Jong Liang,
  • Yi-Ling Lin,
  • Matthew T Whitney,
  • Gwong-Jen J Chang,
  • Sheng-Ren Chen,
  • Shang-Rung Wu,
  • Day-Yu Chao

DOI
https://doi.org/10.7554/eLife.38970
Journal volume & issue
Vol. 7

Abstract

Read online

Dengue fever is caused by four different serotypes of dengue virus (DENV) which is the leading cause of worldwide arboviral diseases in humans. Virus-like particles (VLPs) containing flavivirus prM/E proteins have been demonstrated to be a potential vaccine candidate; however, the structure of dengue VLP is poorly understood. Herein VLP derived from DENV serotype-2 were engineered becoming highly matured (mD2VLP) and showed variable size distribution with diameter of ~31 nm forming the major population under cryo-electron microscopy examination. Furthermore, mD2VLP particles of 31 nm diameter possess a T = 1 icosahedral symmetry with a groove located within the E-protein dimers near the 2-fold vertices that exposed highly overlapping, cryptic neutralizing epitopes. Mice vaccinated with mD2VLP generated higher cross-reactive (CR) neutralization antibodies (NtAbs) and were fully protected against all 4 serotypes of DENV. Our results highlight the potential of ‘epitope-resurfaced’ mature-form D2VLPs in inducing quaternary structure-recognizing broad CR NtAbs to guide future dengue vaccine design.

Keywords